CDX-3379
CDX-3379 is a humanized monoclonal antibody inhibitor targeting ErbB3. CDX-3379 binds to ErbB3, blocking the dimerization of ErbB3 with other receptors, thereby inhibiting the phosphorylation of ErbB3. CDX-3379 can inhibit the growth and proliferation of tumor cells. CDX-3379 is promising for research of tumors expressing ErbB3 and NRG1, such as HNSCC[1].
Product Specifications
UNSPSC
12352203
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
References & Citations
[1]Duvvuri U, et al. Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma Patients. Clin Cancer Res. 2019 Oct 1;25 (19) :5752-5758.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Isoform
ErbB3/HER3
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Polyclonal ASCL1/Mash1 Antibody [CoraFluor 1]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
NBP2-99418CL1 0.1 mL
Rabbit Polyclonal ASCL1/Mash1 Antibody [CoraFluor 1]
Sign In for Pricing
View Details 
K0290302 1.0 µg DNA
C12orf35 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
